CAS 1188275-92-4

Narnatumab

CAS: 1188275-92-4

Narnatumab (IMC-RON8) is a humanized antibody that targets the macrophage-stimulating receptor 1 (RON). Narnatumab blocks the binding of RON to its ligand, macrophage-stimulating protein (MSP), and inhibits receptor activation, thereby suppressing tumor cell proliferation and migration. It is being investigated for the treatment of advanced malignant solid tumors.

Reinheit: >95%

Farbe und Form: Liquid

Molekulargewicht: 145.8 kDa (Predicted)

Ref: TM-T77409

Narnatumab

CAS: 1188275-92-4

Reinheit: 95%

Molekulargewicht: G/Mol

Ref: IN-DA0294VP